http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#Head http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#provenance http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#pubinfo http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion http://purl.obolibrary.org/obo/DOID_13268 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_13268 http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01174 http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association http://www.w3.org/2000/01/rdf-schema#label "Barbiturates are contraindicated in patients with known barbiturate sensitivity. Barbiturates are also contraindicated in patients with a history of manifest or latent porphyria, marked impairment of liver functions or with severe respiratory distress where dyspnea or obstruction is evident. Large doses are contraindicated in nephritic subjects. Barbiturates should not be administered to persons with known previous addiction to the sedative-hypnotic group since ordinary doses may be ineffectual and may contribute to further addiction. Intraarterial administration is contraindicated. Its consequences vary from transient pain to gangrene. Subcutaneous administration produces tissue irritation, ranging from tenderness and redness to necrosis and is not recommended. (See DOSAGE AND ADMINISTRATION, Treatment of Adverse Effects Due to Inadvertent Error in Administration" http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01174 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#provenance http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#pubinfo http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig http://purl.org/nanopub/x/hasSignature IQg/HJ/OWImLc07tN/VnRHA3oF4CnZNSPYY5VCCSoDriJA0guK1AcndMrVIPUWsjG3QTS+gUbK1a0huPXBDz2Ei+Zj6rLW31tdyOg2kC7mpPQv2EqXjV/7LcvZilbkVTayp6psE/IKGLRJ8wd7Ggaz0wDOcvfjz+FTnMOYLwu1c= http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://purl.org/dc/terms/created 2021-08-23T18:04:31.262+02:00 http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY